Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 1.00 |
| ▸ | TTR | P02766 | 1/20 | 0.71 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.69 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.67 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.67 |
| ▸ | STAT3 | P40763 | 2/20 | 0.67 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.67 |
| ▸ | RELA | Q04206 | 2/20 | 0.67 |
| ▸ | XDH | P47989 | 1/20 | 0.67 |
| ▸ | APP | P05067 | 5/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | CA12 | O43570 | 2/20 | 0.65 |
| ▸ | CA1 | P00915 | 2/20 | 0.65 |
| ▸ | CA2 | P00918 | 2/20 | 0.65 |
| ▸ | CA3 | P07451 | 2/20 | 0.65 |
| ▸ | PKM | P14618 | 2/20 | 0.65 |
| ▸ | CA4 | P22748 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isoeugenol SCHEMBL300766 | 1.00 | TYR (1.00) | TYRTTRNFE2L2ALOX5CYP2D6 | |
| Cis/Trans-Isoeugenol SCHEMBL29361918 | 1.00 | TYR (1.00) | TYRTTRNFE2L2ALOX5CYP2D6 | |
| Isoeugenol SCHEMBL57986 | 1.00 | TYR (1.00) | TYRTTRNFE2L2ALOX5CYP2D6 | |
| Isoeugenol SCHEMBL29369838 | 1.00 | TYR (1.00) | TYRTTRNFE2L2ALOX5CYP2D6 | |
| Cis/Trans-Isoeugenol SCHEMBL2463283 | 1.00 | TYR (1.00) | TYRTTRNFE2L2ALOX5CYP2D6 | |
| Cis/Trans-Isoeugenol SCHEMBL57987 | 1.00 | TYR (1.00) | TYRTTRNFE2L2ALOX5CYP2D6 | |
| Cis/Trans-Isoeugenol SCHEMBL112938 | 0.98 | TYR (0.96) | TYRTTRNFE2L2ALOX5CYP2D6 | |
| Isoeugenol SCHEMBL21623923 | 0.98 | TYR (0.96) | TYRTTRNFE2L2ALOX5CYP2D6 | |
| Cis/Trans-Isoeugenol SCHEMBL21623924 | 0.98 | TYR (0.96) | TYRTTRNFE2L2ALOX5CYP2D6 | |
| Isoeugenol SCHEMBL432121 | 0.98 | TYR (0.96) | TYRTTRNFE2L2ALOX5CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109836312-A | A kind of synthetic method of isoeugenol methyl ether | 南京林业大学 | 2019-06-04 | — | — | CN | claimed |
| US-9241886-B2 | Dye composition using a particular phenolic coupler in a medium rich in fatty substances, processes and devices | L'OREAL (FR) | 2016-01-26 | — | — | US | claimed |
| CN-104651049-A | Preparation of essence having fragrance of carnation | TIANJIN BOLAIEN TECHNOLOGY DEV CO LTD | 2015-05-27 | — | — | CN | claimed |
| US-20140053346-A1 | DYE COMPOSITION USING A PARTICULAR PHENOLIC COUPLER IN A MEDIUM RICH IN FATTY SUBSTANCES, PROCESSES AND DEVICES | L'OREAL (FR) | 2014-02-27 | — | — | US | claimed |
| EP-4048094-B1 | NOVEL AEROSOL-GENERATING SUBSTRATE COMPRISING ILLICIUM SPECIES | PHILIP MORRIS PRODUCTS SA (CH) | 2023-11-29 | — | — | EP | disclosed |
| EP-4282285-A2 | NOVEL AEROSOL-GENERATING SUBSTRATE COMPRISING ILLICIUM SPECIES | Philip Morris Products S.A. (CH) | 2023-11-29 | — | — | EP | disclosed |
| US-11062794-B2 | Olfactory signature and odorant mixture having the same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-07-13 | — | — | US | disclosed |
| CN-109298082-B | Method for identifying artificial essence added in tea | 广东省农业科学院茶叶研究所 | 2021-07-02 | — | — | CN | disclosed |
| WO-2021078683-A1 | NOVEL AEROSOL-GENERATING SUBSTRATE COMPRISING ILLICIUM SPECIES | PHILIP MORRIS PRODUCTS S.A. (CH) | 2021-04-29 | — | — | WO | disclosed |
| US-20190240187-A1 | ORAL PREPARATIONS WITH OMEPRAZOLE OR PANTOPRAZOLE | SYMRISE AG (DE) | 2019-08-08 | — | — | US | disclosed |
| CN-109836312-A | A kind of synthetic method of isoeugenol methyl ether | 南京林业大学 | 2019-06-04 | — | — | CN | disclosed |
| CN-109314245-A | Binder composition for non-aqueous secondary battery electrode, non-aqueous secondary battery slurry composition for electrode, non-aqueous secondary battery electrode and non-aqueous secondary battery | 日本瑞翁株式会社 | 2019-02-05 | — | — | CN | disclosed |
| US-20140053346-A1 | DYE COMPOSITION USING A PARTICULAR PHENOLIC COUPLER IN A MEDIUM RICH IN FATTY SUBSTANCES, PROCESSES AND DEVICES | L'OREAL (FR) | 2014-02-27 | — | — | US | disclosed |
| WO-2013189694-A2 | COSMETIC AND DERMATOLOGICAL PREPARATION CONTAINING ONE OR MORE SUBSTANCES WHICH MODULATE THE GENE / PROTEIN FOR THE ENDO180 RECEPTOR | BEIERSDORF AG (DE) | 2013-12-27 | — | — | WO | disclosed |
| WO-2013035070-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2013-03-14 | — | — | WO | disclosed |
| EP-2555763-A1 | VIRAL INHIBITOR COMPOSITIONS FOR IN VIVO THERAPEUTIC USE COMPRISING A COMBINATION OF (-) -CARVONE, GERANIOL AND A FURTHER ESSENTIAL OIL COMPONENT | Cesa Alliance S.A. (LU) | 2013-02-13 | — | — | EP | disclosed |
| WO-2011117424-A1 | VIRAL INHIBITOR COMPOSITIONS FOR IN VIVO THERAPEUTIC USE COMPRISING A COMBINATION OF (-) -CARVONE, GERANIOL AND A FURTHER ESSENTIAL OIL COMPONENT | CESA ALLIANCE S.A. (LU) | 2011-09-29 | — | — | WO | disclosed |
| US-20090178692-A1 | PERSONAL CLEANSING SYSTEM | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-07-16 | — | — | US | disclosed |
| EP-2070510-A1 | Personal cleansing system | Takasago International Corporation (JP) | 2009-06-17 | — | — | EP | disclosed |
| EP-1894603-A1 | Encapsulation of bulky fragrance molecules | Takasago International Corporation (JP) | 2008-03-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190240187-A1 | ORAL PREPARATIONS WITH OMEPRAZOLE OR PANTOPRAZOLE | PPIP5K2, CYP8B1, CYP3A43 | TYR 3490/4885TTR 1163/4885NFE2L2 2582/4885 |
| US-20140053346-A1 | DYE COMPOSITION USING A PARTICULAR PHENOLIC COUPLER IN A MEDIUM RICH IN FATTY SUBSTANCES, PROCESSES AND DEVICES | C1R, F12, AKR1C3 | TYR 223/4885TTR 1690/4885NFE2L2 1053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.